The Clorox Company announced the appointment of Fabian Garcia as its new Chief Executive Officer and a member of the Board, effective January 5, 2027. Garcia will succeed Linda Rendle, who is stepping down as CEO and Chair. Rendle will serve as a senior advisor until April 2, 2027, to ensure a smooth transition. Additionally, Lead Independent Director Matthew J. Shattock will assume the role of Independent Chair of the Board.

Key Details

  • Leadership Transition: Fabian Garcia, currently President of Personal Care at Unilever, will become CEO effective January 5, 2027. Linda Rendle will step down and serve as a senior advisor through April 2, 2027.
  • New CEO Compensation: Garcia's offer includes a one-time sign-on RSU award valued at $11 million, a target annual long-term incentive award of $9.1 million, and a target annual bonus of $2 million.
  • Board Changes: Matthew J. Shattock, the current Lead Independent Director, will become the Independent Chair of the Board, receiving a $225,000 annual retainer for the role.